Log in to save to my catalogue

Silencing of galectin‐3 changes the gene expression and augments the sensitivity of gastric cancer c...

Silencing of galectin‐3 changes the gene expression and augments the sensitivity of gastric cancer c...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11159305

Silencing of galectin‐3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents

About this item

Full title

Silencing of galectin‐3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents

Publisher

Oxford, UK: Blackwell Publishing Ltd

Journal title

Cancer science, 2010-01, Vol.101 (1), p.94-102

Language

English

Formats

Publication information

Publisher

Oxford, UK: Blackwell Publishing Ltd

More information

Scope and Contents

Contents

Galectin‐3 is known to modulate cell proliferation and apoptosis and is highly expressed in human cancers, but its function in gastric cancer is still controversial. Here, we examined the role of galectin‐3 in gastric cancer cells by silencing it with synthetic double‐stranded siRNA. After silencing of galectin‐3, cell numbers decreased and cell sh...

Alternative Titles

Full title

Silencing of galectin‐3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11159305

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11159305

Other Identifiers

ISSN

1347-9032,1349-7006

E-ISSN

1349-7006

DOI

10.1111/j.1349-7006.2009.01364.x

How to access this item